22
Oct
Avandia Information
Posted under: Uncategorized by DreamLegalTeam
Type 2 is the most common form of diabetes. The body does not produce enough insulin or the cells ignore the insulin. Fortunately, we are learning much more about Type 2 diabetes and a person diagnosed with this serious disease can live a long and happy life. The American Diabetes Association says that there are 23.6 million Americans with diabetes. Of that amount, 5.7 million have not yet been diagnosed.
In 1999, GlaxoSmithKline received approval for a drug for treatment of Type 2 diabetes called Avandia.
On May 21, 2007, the U.S. Food and Drug Administration published a safety alert for Avandia. The report states that “…Safety data from controlled clinical trials have shown that there is a potentially significant increase in the risk of heart attack and heart-related deaths in patients taking Avandia…” The warning goes on to state that GlaxoSmithKline provided the F.D.A. with a pooled analysis of “…42 randomized, controlled clinical trials in which Avandia was compared to either placebo or other anti-diabetic therapies in patients with Type 2 diabetes. The pooled analysis suggested that patients receiving short-term (most studies were 6-months duration) treatment with Avandia may have a 30-40 percent greater risk of heart attack and other heart-related adverse events that patients treated with placebo or other anti-diabetic therapy. These data, if confirmed, would be of significant concern since patients with diabetes are already at an increased risk of heart disease…”
If you or someone you love has been taking Avandia to treat Type 2 diabetes and has had a heart attack or other heart-related adverse events, you need to speak to an attorney who is knowledgeable and experienced with these cases. I would like to invite you to fill out an online consultation form or engage in a live chat. Don’t wait.
Good, bad or ugly, tell us what you think of this blog!

